Czech Republic opens door to psychedelic therapy for mental health conditions

The Czech Parliament has passed a significant law allowing psilocybin therapy for mental health conditions like depression, anxiety, and addiction. This groundbreaking decision will enable qualified psychiatrists to administer psilocybin in accredited clinical settings, under professional supervision.
If confirmed by the Senate, Czechia will join countries like Switzerland, Canada, and Australia in leading the way with medical psychedelic use.

At PAREA, we applaud this responsible and evidence-based approach, which offers a model for safe, regulated integration of psychedelic therapies in clinical practice. This move not only advances mental health treatment but also re-establishes the Czech Republic’s legacy as a leader in psychedelic research.

Read the full news release here.